Published in Exp Hematol on February 01, 1992
Survival of patients with breast cancer attending Bristol Cancer Help Centre. Lancet (1990) 7.04
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J Clin Oncol (1997) 5.89
Comparison of autoclave and ethylene oxide-sterilized membrane filters used in water quality studies. Appl Microbiol (1974) 4.37
Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation. Lancet (1980) 4.21
Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Lancet (2005) 3.75
Eukaryotic DNA polymerase amino acid sequence required for 3'----5' exonuclease activity. Proc Natl Acad Sci U S A (1991) 3.44
Management of adult acute myelogenous leukaemia. Br Med J (1973) 3.33
Combined management of malignant teratoma of the testis. Lancet (1979) 3.12
Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial. Lancet (2000) 2.72
Immunotherapy for acute myelogenous leukaemia. Br J Cancer (1973) 2.67
Recognition of leukaemia cells as foreign before and after autoimmunization. Br Med J (1971) 2.50
Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II. Cancer Chemother Pharmacol (1982) 2.50
Cyclosporin A for the treatment of graft-versus-host disease in man. Lancet (1979) 2.48
High-dose intravenous melphalan for plasma-cell leukaemia and myeloma. Lancet (1983) 2.33
The place of bone-marrow transplantation in acute myelogenous leukaemia. Lancet (1980) 2.03
Incidence of R factors in coliform, fecal coliform, and Salmonella populations of the Red River in Canada. Appl Environ Microbiol (1980) 2.00
Parenteral acyclovir therapy for herpesvirus infections in man. Lancet (1979) 1.99
Protected P-element termini suggest a role for inverted-repeat-binding protein in transposase-induced gap repair in Drosophila melanogaster. Genetics (1995) 1.89
Molecular interactions between Vestigial and Scalloped promote wing formation in Drosophila. Genes Dev (1998) 1.89
The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP). Br J Cancer (1983) 1.84
Control of Drosophila wing and haltere development by the nuclear vestigial gene product. Genes Dev (1991) 1.81
Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial. Br J Cancer (1999) 1.80
Reduced lethality in mice receiving a combined dose of cyclophosphamide and busulphan. Br J Cancer (1975) 1.77
Responses to a clinical test of mechanical provocation of nerve tissue in whiplash associated disorder. Man Ther (2002) 1.76
Enhanced post-irradiation recovery of the haemopoietic system in animals pretreated with a variety of cytotoxic agents. Cell Tissue Kinet (1978) 1.76
Oral non-absorbed antibiotics prevent infection in acute non-lymphoblastic leukaemia. Lancet (1977) 1.69
The DNA sequence and genetic organization of a Neurospora mitochondrial plasmid suggest a relationship to introns and mobile elements. Cell (1984) 1.57
Does donor-recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia? Bone Marrow Transplant (2002) 1.49
Effect of high-dose melphalan on marrow and intestinal epithelium in mice pretreated with cyclophosphamide. Br J Cancer (1978) 1.48
Prevention of breast cancer with tamoxifen--an update on the Royal Marsden Hospital pilot programme. Eur J Cancer (1990) 1.47
Non-seminoma germ cell tumours (malignant teratoma) of the testis. Results of treatment and an analysis of prognostic factors. Br J Urol (1981) 1.46
Outcome of biphenotypic acute leukemia. Haematologica (1999) 1.46
Peripheral blood stem cell transplantation may result in increased relapse of acute myeloid leukaemia due to reinfusion of a higher number of malignant cells. Bone Marrow Transplant (1995) 1.45
Harnessing engineered antibodies of the IgE class to combat malignancy: initial assessment of FcɛRI-mediated basophil activation by a tumour-specific IgE antibody to evaluate the risk of type I hypersensitivity. Clin Exp Allergy (2011) 1.45
Vaginal stenosis following allogeneic bone marrow transplantation for acute myeloid leukaemia. Bone Marrow Transplant (1999) 1.45
A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease. Br J Cancer (1977) 1.43
Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient. Br J Cancer (1977) 1.43
CDC group IV c-2 infection in a stem cell transplant recipient. Bone Marrow Transplant (1997) 1.43
Aggressive management of non-small cell lung cancer with synchronous solitary brain metastasis. Clin Oncol (R Coll Radiol) (2004) 1.42
Guidelines on the insertion and management of central venous access devices in adults. Int J Lab Hematol (2007) 1.42
Remission of Crohn's disease following allogeneic bone marrow transplant for acute leukaemia. Hosp Med (1998) 1.42
Methotrexate-induced malabsorption in children with acute lymphoblastic leukaemia. Br Med J (1977) 1.41
Acceleration of bone-marrow recovery by pre-treatment with cyclophosphamide in patients receiving high-dose melphalan. Lancet (1978) 1.40
Snai1 and Snai2 collaborate on tumor growth and metastasis properties of mouse skin carcinoma cell lines. Oncogene (2008) 1.40
A phase I evaluation of the quinazoline antifolate thymidylate synthase inhibitor, N10-propargyl-5,8-dideazafolic acid, CB3717. J Clin Oncol (1986) 1.40
Suppression of carbamazepine-induced rash with prednisone. Neurology (1991) 1.39
High-dose methylprednisolone sodium succinate as a single agent in relapsed childhood acute lymphoblastic leukaemia. Med Pediatr Oncol (1992) 1.39
High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma. Br J Cancer (1982) 1.37
Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia. J Clin Oncol (2000) 1.36
Combination chemotherapy in advanced and recurrent Hodgkin's disease. Natl Cancer Inst Monogr (1973) 1.33
Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia. Lancet (1983) 1.31
Active immunotherapy as an adjunct to chemotherapy in the treatment of disseminated malignant melanoma: a pilot study. Br J Cancer (1975) 1.31
Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group. Lancet (1994) 1.29
A cell line secreting stimulating factors for CFU-GEMM culture. Blood (1984) 1.27
Isolation of salmonella from moderately polluted waters. J Water Pollut Control Fed (1973) 1.27
Conception and congenital abnormalities after chemotherapy of acute myelogenous leukaemia in two men. Br Med J (1976) 1.26
Testicular tumours. Clin Endocrinol Metab (1975) 1.20
Three years' experience with Ch1VPP (a combination of drugs of low toxicity) for the treatment of Hodgkin's disease. Br J Cancer (1979) 1.19
Properties of rat adrenal zona reticularis cells: preparation by gravitational sedimentation. J Endocrinol (1978) 1.17
Influence of sewage treatment and urbanization on selection of multiple resistance in fecal coliform populations. Appl Environ Microbiol (1983) 1.17
Etoposide as a single agent in relapsed advanced lymphomas. A phase II study. Cancer Chemother Pharmacol (1982) 1.15
A P element chimera containing captured genomic sequences was recovered at the vestigial locus in Drosophila following targeted transposition. Genetics (1992) 1.15
Autocrine function for insulin-like growth factor I in human small cell lung cancer cell lines and fresh tumor cells. Cancer Res (1990) 1.15
Safe method of collecting leukaemia cells from patients with acute leukaemia for use as immunotherapy. Br Med J (1974) 1.15
Chemotherapy and irradiation in childhood Hodgkin's disease. Arch Dis Child (1984) 1.15
Molecular analysis of hybrid dysgenesis-induced derivatives of a P-element allele at the vg locus. Mol Cell Biol (1988) 1.14
Additional chromosome abnormalities confer worse prognosis in acute promyelocytic leukaemia. Br J Haematol (1997) 1.14
VP16-213 as a single agent in advanced testicular tumors. Eur J Cancer (1980) 1.13
High dose melphalan and non-cryopreserved autologous bone marrow treatment of malignant melanoma and neuroblastoma. Exp Hematol (1979) 1.13
Combination chemotherapy for testicular tumours. Proc R Soc Med (1974) 1.13
Changes in serum amylase and its isoenzymes after whole body irradiation. Br Med J (Clin Res Ed) (1982) 1.13
A study to determine the safety profile and maximum tolerated dose of micafungin (FK463) in patients undergoing haematopoietic stem cell transplantation. Bone Marrow Transplant (2006) 1.12
Combinations of cytotoxic agents that have less than expected toxicity on normal tissues in mice. Antibiot Chemother (1971) (1978) 1.12
Treatment of advanced malignant melanoma with high-dose melphalan and autologous bone marrow transplantation. Br J Cancer (1983) 1.11
Multiple myeloma treated with high dose intravenous melphalan. Br J Haematol (1987) 1.11
Granulocytic sarcoma: a diagnosis to be considered in unusual lymphoma syndromes. Postgrad Med J (1987) 1.10
Investigation of the enzymatic mechanism of yeast orotidine-5'-monophosphate decarboxylase using 13C kinetic isotope effects. Biochemistry (1991) 1.09
Infused vincristine and adriamycin with high dose methylprednisolone (VAMP) in advanced previously treated multiple myeloma patients. Br J Cancer (1988) 1.09
HL-A antibody response in patients with acute myelogenous leukaemia treated by immunotherapy. Transplantation (1975) 1.08
Cholesteryl ester exchange protein in human plasma isolation and characterization. Biochim Biophys Acta (1978) 1.08
Induction of null-activity mutants for the acid phosphatase-1 gene in Drosophila melanogaster. Biochem Genet (1972) 1.07